Velano Vascular Overview
- Year Founded
-
2012
- Status
-
Acquired/Merged
- Employees
-
29
- Latest Deal Type
-
M&A
- Investors
-
1
Velano Vascular General Information
Description
Developer of a needle-free blood collection medical device designed to reduce the risk and inefficiencies of vascular access practices. The company's device is a single-use and sterile device that temporarily attaches to a peripheral IV catheter to collect a fresh venous sample to combat the urgent challenge of vascular access, enabling hospitals to deliver painless and secure healthcare procedures for patients.
Contact Information
Website
www.velanovascular.comCorporate Office
- 221 Pine Street
- Suite 200
- San Francisco, CA 94104
- United States
Corporate Office
- 221 Pine Street
- Suite 200
- San Francisco, CA 94104
- United States
Velano Vascular Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Merger/Acquisition | 20-Jul-2021 | Completed | Out of Business | |||
| 10. Accelerator/Incubator | 23-Aug-2017 | Completed | Generating Revenue | |||
| 9. Debt - PPP | 15-Apr-2020 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 03-Jan-2020 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series B1) | 08-May-2019 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B) | 07-Mar-2017 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A2) | 08-Feb-2016 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A1) | 01-Jan-2015 | Completed | Startup | |||
| 3. Grant | 27-Oct-2014 | $50K | $2.6M | Completed | Startup | |
| 2. Early Stage VC (Series A) | 01-Nov-2013 | $2.45M | $2.6M | Completed | Startup |
Velano Vascular Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B1 | ||||||||
| Series B | ||||||||
| Series A2 | ||||||||
| Series A1 | 446,177 | $0.000100 | 6% | $5.6 | $5.6 | 1x | $5.6 | 7.89% |
| Series A | 828,521 | $0.000100 | 6% | $2.96 | $2.96 | 1x | $2.96 | 14.66% |
Velano Vascular Comparisons
Industry
Financing
Details
Velano Vascular Competitors (5)
One of Velano Vascular’s 5 competitors is Tasso, a Venture Capital-Backed company based in Seattle, WA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Tasso | Venture Capital-Backed | Seattle, WA | ||||
| Spot On Sciences | Private Equity-Backed | San Francisco, CA | ||||
| YourBio Health | Formerly VC-backed | Medford, MA | ||||
| HemaXis | Venture Capital-Backed | Gland, Switzerland | ||||
| Vortex Biosciences | Venture Capital-Backed | Manchester, United Kingdom |
Velano Vascular Patents
Velano Vascular Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2020333843-A1 | Fluid transfer devices with extended length catheters and methods of using the same | Active | 20-Aug-2019 | ||
| AU-2020333843-B2 | Fluid transfer devices with extended length catheters and methods of using the same | Active | 20-Aug-2019 | ||
| CA-3151924-A1 | Fluid transfer devices with extended length catheters and methods of using the same | Pending | 20-Aug-2019 | ||
| EP-4017571-A1 | Fluid transfer devices with extended length catheters and methods of using the same | Pending | 20-Aug-2019 | ||
| EP-4017571-A4 | Fluid transfer devices with extended length catheters and methods of using the same | Pending | 20-Aug-2019 | A61M25/01 |
Velano Vascular Signals
Velano Vascular Former Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| D-W Investments | Real Estate | Minority | ||
| Eastward Capital Partners | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| First Round Capital | Venture Capital | Minority | ||
| Griffin Hospital | Corporation | Minority |
Velano Vascular FAQs
-
When was Velano Vascular founded?
Velano Vascular was founded in 2012.
-
Where is Velano Vascular headquartered?
Velano Vascular is headquartered in San Francisco, CA.
-
What is the size of Velano Vascular?
Velano Vascular has 29 total employees.
-
What industry is Velano Vascular in?
Velano Vascular’s primary industry is Medical Supplies.
-
Is Velano Vascular a private or public company?
Velano Vascular is a Private company.
-
What is Velano Vascular’s current revenue?
The current revenue for Velano Vascular is .
-
How much funding has Velano Vascular raised over time?
Velano Vascular has raised $61.8M.
-
Who are Velano Vascular’s investors?
D-W Investments, Eastward Capital Partners, , First Round Capital, and Griffin Hospital are 5 of 17 investors who have invested in Velano Vascular.
-
Who are Velano Vascular’s competitors?
Tasso, Spot On Sciences, YourBio Health, HemaXis, and Vortex Biosciences are competitors of Velano Vascular.
-
When was Velano Vascular acquired?
Velano Vascular was acquired on 20-Jul-2021.
-
Who acquired Velano Vascular?
Velano Vascular was acquired by Becton, Dickinson and Company.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process